(Q30327955)

18 June 2017

1 reference

title

Zanamivir: a rational approach to influenza B. (English)

1 reference

18 June 2017

1 reference

Penn CR

1

1 reference

18 June 2017

Osterhaus A

series ordinal

2

1 reference

18 June 2017

publication date

1 January 2001

1 reference

18 June 2017

1 reference

18 June 2017

volume

33

1 reference

18 June 2017

issue

1

1 reference

18 June 2017

page(s)

33-40

1 reference

The impact of influenza epidemics on mortality: introducing a severity index.

18 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Acute respiratory illness in the community. Frequency of illness and the agents involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

The effectiveness of vaccination against influenza in healthy, working adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Rational design of potent sialidase-based inhibitors of influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

Socioeconomics of influenza and influenza vaccination in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750064040

10.1080/003655401750064040

21 January 2018

Identifiers

DOI

1 reference

18 June 2017

1 reference